NAVAMEDIC (NAVA.OL) Stock Income Statement
Europe - Euronext Oslo - OSL:NAVA - NO0010205966 - Common Stock
21.8 NOK
-0.1 (-0.46%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 539.42M | 531.44M | 512.00M | 382.13M | 278.40M | |||
| Cost Of Goods | 338.08M | 322.56M | 312.94M | 218.62M | 166.70M | |||
| Gross Profit | 201.33M | 208.88M | 199.05M | 163.52M | 111.70M | |||
| Operating Expenses | 185.20M | 177.08M | 159.41M | 119.08M | 100.30M | |||
| Selling, General, and Administrative Expenses | N/A | 122.65M | 114.88M | 48.09M | 44.50M | |||
| Operating Income | 16.13M | 31.80M | 39.64M | 44.44M | 11.50M | |||
| Interest Income/Expense | -44.10M | -14.74M | -5.91M | -8.65M | -7.20M | |||
| Other Income/Expense | N/A | -6.83M | -6.43M | -2.80M | -1.90M | |||
| Non Recurring Items | N/A | -11.85M | -33.46M | 9.51M | N/A | |||
| Income Before Taxes | -36.03M | -1.62M | -6.16M | 42.51M | 2.40M | |||
| Income Tax | 3.39M | 3.87M | 7.53M | 13.07M | 1.70M | |||
| Net Income | -39.43M | -5.49M | -13.69M | 29.43M | 600.00K | |||
| EBITDA | N/A | 72.14M | 51.57M | 51.69M | 18.22M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.21 | -0.31 | -0.78 | 1.68 | 0.04 | |||
| Statistics | ||||||||
| Gross Profit Margin | 37.32% | 39.30% | 38.88% | 42.79% | 40.12% | |||
| Profit Margin | -7.31% | -1.03% | -2.67% | 7.70% | 0.22% | |||
| Operating Profit Margin | 2.99% | 5.98% | 7.74% | 11.63% | 4.13% | |||
All data in NOK